Gila Therapeutics
Gila Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Seed, 1 tracked investor.
About Gila Therapeutics
Based in the United States, Gila Therapeutics is a startup. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Gila Therapeutics is a clinical-stage biotech company developing a topical lingual signaling platform that delivers micro-dose PYY and GLP-1 melts on the tongue to target brain regions regulating food intake and metabolism, aiming to treat obesity, type 2 diabetes, and cardiometabolic disorders without systemic exposure.
Explore Gila Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.